
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 06, 2024, titled "Aurobindo Pharma receives USFDA approval for Estradiol Vaginal Inserts USP, 10 mcg".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 06, 2024, titled "Aurobindo Pharma receives USFDA approval for Estradiol Vaginal Inserts USP, 10 mcg".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma